Progressive supranuclear palsy is one of the more common atypical Parkinson’s syndromes, with an average duration of 5-9 years.
The average duration of progressive supranuclear palsy is 5 to 9 years, with some types lasting longer than 13 years. However, it is not possible to generalize the exact duration of life, and the survival of patients is related to clinical staging, comorbidities, and early clinical intervention.
There is no effective treatment for progressive supranuclear palsy with the current medical treatment, and levodopa and other drugs are used to relieve symptoms.
It is recommended that patients with progressive supranuclear palsy receive timely treatment in the hospital after diagnosis and maintain an optimistic and positive attitude.